Dapagliflozin Shows Added Cardiac Benefits Over Linagliptin in T2DM with Heart Failure: Study
A new study published in the journal of Medicine showed that both linagliptin and dapagliflozin have good safety profiles and successfully enhance cardiac function and glycemic management in individuals with…